ArticleClinical hematology international2025

Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective study.

Nicolas Stocker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.